The page is the record's research on the issuer — no analyst, no rating, no view. # Chiome Bioscience Inc. (Growth Market: 4583) — research page As of 2026-11-06 · jp-cm-kg · record version 1 ## Identity and listing The issuer is Chiome Bioscience Inc., listed on the Growth Market under ticker 4583. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate and the segment is not on the record. The sector is 3250 Pharmaceutical and the jurisdiction is Japan (EDINET domestic filer). The issuer is listed and not halted. ## The disclosure read The record holds 8 filings in the twelve months to 2026-11-06, across 4 filing days. The median gap between filing days is 93 days. The latest filing is dated 2026-08-13 and is of type results, 85 days before the record date of 2026-11-06. The Growth Market median cadence gap is 42 days across 598 issuers, and the Growth Market median latency is 85.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days across 80 issuers, and the sector median latency is 85.0 days. The issuer's median filings count is 8 and the Growth Market and sector medians are both 8.0. ## Auditor The auditor of record is 太 陽 有 限 責 任 監 査 法 人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed and not halted. ## Orderability For the client category Qualified Institutional Investors, the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research The record holds 4 openly published research notes. They are from Omega Investment dated 2023-12-12, Omega Investment dated 2023-06-01, Omega Investment dated 2021-08-23, and FISCO Ltd. dated 2014-10-27. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed, and no earliest sealed date for the market is on the record. The live record began date is not on the record. ## Sources 11 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange) - https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction) - https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/4583 (the disclosure lines) - https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag) - https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUJT (the auditor) - https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter) - https://omega-inv.com/wp-content/uploads/2023/12/4583CBS2023Q3_EN1212.pdf (open research) - https://omega-inv.com/wp-content/uploads/2023/05/4583CBS2023Q1_EN0601.pdf (open research) - https://omega-inv.com/en/wp-content/uploads/sites/2/2021/08/4583CB2021Q2UD0827EN.pdf (open research) - https://www.fisco.co.jp/wordpress/wp-content/uploads/chiom20141027_e.pdf (open research) - https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/4583 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-GROWTH/4583 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp